LOTUS: Global Acute Stroke Study Utilizing Penumbra System

NCT04157270 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 23

Last updated 2021-06-25

No results posted yet for this study

Summary

The primary objective of this study is to demonstrate safety and effectiveness of the Penumbra System in a population with acute ischemic stroke (AIS) secondary to intracranial large vessel occlusion (LVO).

Conditions

  • Stroke, Ischemic

Interventions

DEVICE

Penumbra System

Penumbra System

Sponsors & Collaborators

  • Penumbra Inc.

    lead INDUSTRY

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-12
Primary Completion
2021-05-10
Completion
2021-05-10
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04157270 on ClinicalTrials.gov